# \[e-drug\] ADRs and cox 2 inhibitors (cont) **URL:** \ **Category:** e-drug\ **Created:** [August 30, 2000, 4:57am UTC](https://talk.edrugplus.org/t/e-drug-adrs-and-cox-2-inhibitors-cont/9029 "2000-08-30T04:57:34Z")\ **Posts on this page:** 1\ **Page:** 1
**Author:** ![peter.mansfield](https://avatars.discourse-cdn.com/v4/letter/p/c77e96/32.png) [@peter.mansfield](https://talk.edrugplus.org/u/peter.mansfield)\ **Post date:** [August 30, 2000, 4:57am UTC](https://talk.edrugplus.org/t/e-drug-adrs-and-cox-2-inhibitors-cont/9029/1 "2000-08-30T04:57:34Z")
E-drug: ADRs and cox 2 inhibitors (cont) --------------------------------------------- The March/April 2000 edition of the MaLAM International Newsletter provides a sceptical analysis of Pfizer and Searle�s promotion of celecoxib in Australia. If you have access to www then visit [http://www.camtech.net.au/malam/editions/IN0004.htm](http://www.camtech.net.au/malam/editions/IN0004.htm) If not then ask me to send you the text without the pictures by e-mail. regards, Peter Dr Peter Mansfield GP and consultant on marketing and appropriate therapeutics Visiting lecturer, Universities of Adelaide, Flinders, South Australia, Tasmania Cardiovascular adviser, Adelaide Western Division of General Practice Primary author, Healthy Scepticism Director, MaLAM (Medical Lobby for Appropriate Marketing) MaLAM aims to protect compassionate scientific health care from marketing practices that may be detrimental to health. peter.mansfield@flinders.edu.au www.malam.asn.au PO Box 172 Daw Pk SA 5041 Australia ph/fax +61 8 8374 2245 -- Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'. Mail administrative requests to `majordomo@usa.healthnet.org'. For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.